On the other hand, the payoff could be substantial since this is one product that is in demand - but only if it works. AIDS experts don't believe the vaccine will be of significant value, as it is made from one virus strain, and does not represent the various strains present around the globe. Additionally, research in monkeys have shown that antibodies alone will not provide the sterilizing immunity that VaxGen is touting. Mean while, the company is presenting a series how AIDSs' vaccines are made. Such Information is neither an offer to sell nor a solicitation to buy the securities of any company.
Additional information is available upon request.
Information in this publication has been obtained from sources believed to be reliable, but the accuracy, completeness and interpretation are not guaranteed. Opinions expressed are subject to change without notice. The Information is supplied on the condition that the reader or any other person receiving the Information will make his or her own determination as to its suitability for any purpose prior to any use of the Information. This report may not be reproduced, distributed or published by any recipient for any purpose without the prior express consent of the publishers. Changes in rates of currency exchange may have an adverse effect on the value, price or income of investments.